Think of Enterprise Value as the theoretical takeover price. It is more comprehensive than market capitalization (Market Cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Aroa Biosurgery's Enterprise Value is A$192.50 Mil.
Aroa Biosurgery's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was A$-8.40 Mil. Therefore, Aroa Biosurgery's EV-to-EBIT ratio for today is -22.91.
EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA. As of today, Aroa Biosurgery's Enterprise Value is A$192.50 Mil.
Aroa Biosurgery's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was A$-4.37 Mil. Therefore, Aroa Biosurgery's EV-to-EBITDA ratio for today is -44.04.
EV-to-Revenue is calculated as Enterprise Value divided by its Revenue. As of today, Aroa Biosurgery's Enterprise Value is A$192.50 Mil.
Aroa Biosurgery's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was A$63.36 Mil. Therefore, Aroa Biosurgery's EV-to-Revenue ratio for today is 3.04.
Aroa Biosurgery Enterprise Value Historical Data
The historical data trend for Aroa Biosurgery's Enterprise Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Aroa Biosurgery's Enterprise Value
For the Medical Devices subindustry, Aroa Biosurgery's Enterprise Value, along with its competitors' market caps and Enterprise Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aroa Biosurgery's Enterprise Value Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aroa Biosurgery's Enterprise Value distribution charts can be found below:
* The bar in red indicates where Aroa Biosurgery's Enterprise Value falls into.
Aroa Biosurgery Enterprise Value Calculation
Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash, cash equivalents, and marketable securities.
Aroa Biosurgery's Enterprise Value for the fiscal year that ended in Mar. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aroa Biosurgery (ASX:ARX) Enterprise Value Explanation
When an investor buy a company, the investor needs to pay not only the common shares, he/she also needs to pay the shareholders of Preferred Stocks. He also assumes the debt of the company, and receives the cash on the company's balance sheet.
If a company has more cash than debt, the investor actually pays less than the Market Cap because he immediately owns the cash once the transaction goes through.
The market value of Preferred Stock needs to be added to the market value of common stocks in the calculation of Enterprise Value.
For the companies with the same Market Cap, the smaller the Enterprise Value is, the cheaper the company is.
Enterprise Value can be negative when the company's net cash is more than its Market Cap. In this case the investor is basically getting the company for free and get paid for that.
1. EV-to-EBIT is calculated as Enterprise Value divided by its EBIT.
Aroa Biosurgery's current Enterprise Value is A$192.50 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aroa Biosurgery's EBIT for the trailing twelve months (TTM) ended in Mar. 2024 was A$-8.40 Mil.
2. EV-to-EBITDA is calculated as Enterprise Value divided by its EBITDA.
Aroa Biosurgery's current Enterprise Value is A$192.50 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aroa Biosurgery's EBITDA for the trailing twelve months (TTM) ended in Mar. 2024 was A$-4.37 Mil.
Aroa Biosurgery's current Enterprise Value is A$192.50 Mil.
For company reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data. Aroa Biosurgery's Revenue for the trailing twelve months (TTM) ended in Mar. 2024 was A$63.36 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aroa Biosurgery Enterprise Value Related Terms
Thank you for viewing the detailed overview of Aroa Biosurgery's Enterprise Value provided by GuruFocus.com. Please click on the following links to see related term pages.
Aroa Biosurgery Ltd is a soft tissue regeneration company which develops, manufactures and sells medical devices for wound and soft tissue repair using its proprietary extracellular matrix (ECM) technology. It is focused on improving the rate and quality of healing in complex wounds and soft tissue reconstruction. The Company is in the business of developing, manufacturing and selling soft tissue repair products. The company's principal market is the United States where it has five key products for sale targeting chronic wounds, hernia, plastics, reconstructive surgery and trauma/limb salvage/tumor surgery.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ASX:ARX has been successfully added to your